Max Lugavere on Controversial Alzheimer's Drugs and Studies
September 14, 2022
676,144
15,930
2,024
2.66%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Joe Rogan Episodes Around September 14, 2022
See what was published immediately before and after this episode.
14:46Now PlayingMax Lugavere on Controversial Alzheimer's Drugs and Studies
YouTube Description
as posted by the channelTaken from JRE #1870 w/Max Lugavere:
Links & Promotions
Claims
6 claims extractedAlzheimer's research built on fabricated data and fraud
Alzheimer's drugs have extremely high failure rates and minimal effectiveness
FDA approved ineffective Alzheimer's drug against expert opposition
Adjucanumab caused severe side effects in trial participants
Alternate Alzheimer's research views suppressed by amyloid hypothesis advocates
Alzheimer's drug approval driven by profit motive over patient benefit
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.